Baricitinib shows long-term efficacy for atopic dermatitis

‘Impossible’ to hold Olympics during pandemic, Japan doctors union warns
13 May 2021
Denmark incinerates minks culled over virus fears
13 May 2021

Baricitinib shows long-term efficacy for atopic dermatitis

Baricitinib demonstrates sustained long-term efficacy in patients with moderate-to-severe atopic dermatitis, according to a study published online May 12 in JAMA Dermatology.

Comments are closed.